InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (16 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
16
T+90 hit rate
0%
T+90 mean return
-16.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Koppikar Utpal, Chief Financial Officer. Director active across 3 companies, notably Atara Biotherapeutics, Inc.. Cumulatively, 18 filings have been published. Breakdown: 1 buy · 16 sells. Total volume traded: €642k. History available since 18 May 2021. The latest transaction was filed on 2 March 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations18 total
6,871 shares@ US$3.6275.6% of flowCommon StockSEC:0001567619-23-004538:0
5,667 shares@ US$5.60100.0% of flowCommon StockSEC:0001662579-23-000027:0
Ideal exit: 5 Nov 2023 (T+270)
2,485 shares@ US$5.463.0% of flowCommon StockSEC:0001567619-23-002174:0
5,172 shares@ US$4.495.3% of flowCommon StockSEC:0001140361-22-042378:0
5,940 shares@ US$5.0357.0% of flowCommon StockSEC:0001140361-22-030297:0
5,853 shares@ US$5.630.038% mcap9.3% of flowCommon StockSEC:0001567619-22-012667:0
4,616 shares@ US$5.3160.029% mcap7.0% of flowCommon StockSEC:0001140361-22-019988:0
61,235 shares0Common StockSEC:0001140361-22-007767:0
2,496 shares@ US$14.46150.039% mcap9.5% of flowCommon StockSEC:0001567619-22-003052:0
2,496 shares@ US$14.46150.024% mcap16.4% of flowCommon StockSEC:0001567619-22-003052
3,655 shares@ US$17.116928.7% of flowCommon StockSEC:0001567619-21-020778
3,655 shares@ US$17.11690.067% mcap16.6% of flowCommon StockSEC:0001567619-21-020778:0
3,579 shares@ US$12.53219.9% of flowCommon StockSEC:0001567619-21-016148
3,579 shares@ US$12.5320.047% mcap11.5% of flowCommon StockSEC:0001567619-21-016148:0
5,820 shares@ US$14.060.082% mcap20.2% of flowCommon StockSEC:0001567619-21-011898:0
5,820 shares@ US$14.0635.0% of flowCommon StockSEC:0001567619-21-011898
3,616 shares@ US$14.5513.0% of flowCommon StockSEC:0001209191-21-034424
3,616 shares@ US$14.550.053% mcap13.0% of flowCommon StockSEC:0001209191-21-034424:0
18 of 18 declarations
About Koppikar Utpal
Utpal Koppikar is the Chief Financial Officer at Atara Biotherapeutics, Inc. He is responsible for financial management and strategy for the company. With a strong background in finance, Utpal plays a key role in optimizing financial performance and implementing growth strategies. His expertise in financial analysis is essential for informed decision-making.
